A technique to estimate in vivo dissolution profiles without data from a solution

AAPS Journal

Volumn 14, Issue 3, 2012, Pages 433-436

  Cook, Jack A ^a  

^a PFIZER INC   (United States)

Author keywords

dissolution; in vitro in vivo correlation; permeability

Indexed keywords

METOPROLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DENATURATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; SINGLE DRUG DOSE;

HUMANS; PERMEABILITY; PHARMACOKINETICS; SOLUBILITY;

EID: 84862771517     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9355-4     Document Type: Article

References (9)

1. L Yu 2008 Pharmaceutical quality by design: product and process development, understanding, and control Pharm Res 25 781 791 10.1007/s11095-007-9511-1 18185986 10.1007/s11095-007-9511-1 1:CAS:528:DC%2BD1cXkt1Sntrg%3D
2. PA Dickinson WW Lee PW Stott AI Townsend JP Smart P Ghahramani, et al. 2008 Clinical relevance of dissolution testing in quality by design AAPS J 10 380 390 10.1208/s12248-008-9034-7 18686045 10.1208/s12248-008-9034-7
3. ND Eddington P Marroum R Uppoor A Hussain L Augsburger 1998 Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation Pharm Res 15 3 466 473 10.1023/A:1011988601696 9563079 10.1023/A:1011988601696 1:CAS:528: DyaK1cXisVGqs70%3D Erratum in: Pharm Res 1998;15:1320
4. C Hilgendorf H Spahn-Langguth CG Regårdh E Lipka GL Amidon P Langguth 2000 Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport J Pharm Sci 89 63 75 10.1002/(SICI)1520-6017(200001)89:1<63::AID- JPS7>3.0.CO;2-6 10664539 10.1002/(SICI)1520-6017(200001)89:1<63::AID- JPS7>3.0.CO;2-6 1:CAS:528:DC%2BD3cXit1eisL0%3D
5. D Sun H Lennernas LS Welage JL Barnett CP Landowski D Foster, et al. 2002 Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm Res 19 1400 1416 10.1023/A:1020483911355 12425456 10.1023/A:1020483911355 1:CAS:528:DC%2BD38XnsFSgsLg%3D
6. GL Amidon H Lennernäs VP Shah JR Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 413 420 10.1023/A:1016212804288 7617530 10.1023/A:1016212804288 1:CAS:528: DyaK2MXksVGqur8%3D
7. RS Obach JG Baxter TE Liston BM Silber BC Jones F MacIntyre, et al. 1997 The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data J Pharmacol Exp Ther 283 46 58 9336307 1:CAS:528: DyaK2sXmslCltr0%3D
8. HM Jones IB Gardner WT Collard PJ Stanley P Oxley NA Hosea, et al. 2011 Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling Clin Pharmacokinet 50 331 347 10.2165/11539680-000000000-00000 21456633 10.2165/11539680-000000000-00000 1:CAS:528:DC%2BC3MXntlKlsbc%3D
9. U.S. Department of Health, Food and Drug Administration, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. September 26, 1997.